Encinitas, CA, United States of America

Federico Calzi

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Reshape Lifesciences Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Federico Calzi: Innovator in Intragastric Device Technology

Introduction

Federico Calzi is a notable inventor based in Encinitas, California. He has made significant contributions to the field of medical devices, particularly in the area of obesity treatment. His innovative work focuses on systems and methods for locating and characterizing intragastric devices.

Latest Patents

Calzi holds a patent for "Systems and methods for locating and/or characterizing intragastric devices." This patent outlines devices and methods designed to treat obesity, specifically targeting intragastric devices and providing methods for tracking and locating them. He has 1 patent to his name, showcasing his expertise in this specialized field.

Career Highlights

Calzi is associated with Reshape Lifesciences Inc., a company dedicated to developing innovative solutions for weight management. His role at the company allows him to apply his inventive skills to create impactful medical technologies.

Collaborations

Throughout his career, Calzi has worked alongside talented professionals, including Sheldon Nelson and Mark C. Brister. These collaborations have contributed to the advancement of his projects and the overall mission of Reshape Lifesciences Inc.

Conclusion

Federico Calzi's work in the field of intragastric devices represents a significant advancement in obesity treatment technologies. His innovative patent and collaboration with industry professionals highlight his commitment to improving health outcomes through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…